Assessment of inflammatory and oxidative biomarkers in obesity and their associations with body mass index

Inflammation

Volumn 36, Issue 1, 2013, Pages 226-231

  Piva, Sílvia Juliane ^a   Tatsch, Etiane ^a   De Carvalho, José Antonio Mainardi ^a   Bochi, Guilherme Vargas ^a   Kober, Helena ^a   Duarte, Thiago ^a   Duarte, Marta Maria Medeiros Frescura ^b   Da Cruz, Ivana Beatrice Mânica ^a   Moretto, Maria Beatriz ^a   Moresco, Rafael Noal ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

^b UNIVERSIDADE LUTERANA DO BRASIL   (Brazil)

Author keywords

endothelial dysfunction; inflammation; obesity; oxidative stress

Indexed keywords

ALBUMIN; APOLIPOPROTEIN A; APOLIPOPROTEIN B; BIOLOGICAL MARKER; CHOLESTEROL; CREATININE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; ISCHEMIA MODIFIED ALBUMIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITRATE; NITRITE; TRIACYLGLYCEROL;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CREATININE BLOOD LEVEL; ENDOTHELIAL DYSFUNCTION; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HUMAN; INFLAMMATION; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OBESITY; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

ALBUMINURIA; APOLIPOPROTEINS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY MASS INDEX; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CREATININE; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; INFLAMMATION; INTERLEUKIN-6; MALE; MIDDLE AGED; NITRIC OXIDE; OBESITY; OXIDATIVE STRESS; SERUM ALBUMIN; TRIGLYCERIDES;

EID: 84872969237     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-012-9538-2     Document Type: Article

References (35)

1. Flegal, K.M., M.D. Carroll, C.L. Ogden, and L.R. Curtin. 2010. Prevalence and trends in obesity among US adults, 1999-2008. Journal of the American Medical Association 303: 235-241.
2. Hotamisligil, G.S. 2006. Inflammation and metabolic disorders. Nature 444: 860-867. (Pubitemid 46024993)
3. Shoelson, S.E., J. Lee, and A.B. Goldfine. 2006. Inflammation and insulin resistance. The Journal of Clinical Investigation 116: 1793-1801.
4. Tilg, H., and A.R. Moschen. 2006. Adipocytokines: Mediators linking adipose tissue, inflammation and immunity. Nature Reviews Immunology 6: 772-783. (Pubitemid 44453463)
5. Grundy, S.M., H.B. Brewer, J.I. Cleeman, S.C. Smith, and C. Lenfant. 2004. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109: 433-438. (Pubitemid 38133916)
6. Vassalle, C., L. Pratali, C. Boni, A. Mercuri, and R. Ndreu. 2008. An oxidative stress score as a combined measure of the pro-oxidant and anti-oxidant counterparts in patients with coronary artery disease. Clinical Biochemistry 41: 1162-1167.
7. Li, Q., and I.M. Verma. 2002. NF-kappaB regulation in the immune system. Nature Reviews Immunology 2: 725-734. (Pubitemid 37328713)
8. Lowe, G.D.O., A. Rumley, A.D. McMahon, I. Ford, D.S. O'Reilly, and C.J. Packard. 2004. Interleukin-6, fibrin D-dimer, and coagulation factors VII and XIIa in prediction of coronary heart disease. Arteriosclerosis, Thrombosis, and Vascular Biology 24: 1529-1534. (Pubitemid 39050452)
9. Roytblat, L., M. Rachinsky, A. Fisher, L. Greemberg, Y. Shapira, A. Douvdevani, and S. Gelman. 2000. Raised interleukin-6 levels in obese patients. Obesity Research 8: 673-675.
10. Futrakul, N., V. Sridama, and P. Futrakul. 2009. Microalbuminuria - A biomarker of renal microvascular disease. Renal Failure 31: 140-143.
11. Hillege, H.L., V. Fidler, G.F. Diercks, W.H. van Gilst, D. de Zeeuw, D.J. van Veldhuisen, R.O. Gans, W.M. Janssen, D.E. Grobbee, and P.E. de Jong. 2002. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 106: 1777-1782.
12. Zou, M.H., R. Cohen, and V. Ullrich. 2004. Peroxynitrite and vascular endothelial dysfunction in diabetes mellitus. Endothelium 11: 89-97. (Pubitemid 39207182)
13. Sánchez, A.F., E.M. Santillán, M. Bautista, J.E. Soto, A.M. González, C.E. Chirino, I.D. Montiel, G.S. Rivera, C.V. Veja, and J.A.M. González. 2011. Inflammation, oxidative stress, and obesity. International Journal of Molecular Sciences 12: 3117-3132.
14. Higashi, Y., S. Sasaki, K. Nakagawa, H. Matsuura, K. Chayama, and T. Oshima. 2001. Effect of obesity on endothelium-dependent, nitric oxide-mediated vasodilation in normotensive individuals and patients with essential hypertension. American Journal of Hypertension 14: 1038-1045. (Pubitemid 32978077)
15. Bourdon, E., N. Loreau, and D. Blache. 1999. Glucose and free radicals impair the antioxidant properties of serum albumin. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology 13: 233-244. (Pubitemid 29072400)
16. Piva, S.J., M.M.F. Duarte, I.B. da Cruz, A.C. Coelho, A.P. Moreira, R. Tonello, S.C. Garcia, and R.N. Moresco. 2011. Ischemia-modified albumin as an oxidative stress biomarker in obesity. Clinical Biochemistry 44: 345-347.
17. Newman, D.J., M.J. Pugia, J.A. Lott, J.F. Wallace, and A. Hiar. 2000. Urinary protein and albumin excretion corrected by creatinine and specific gravity. Clinica Chimica Acta 294: 139-155. (Pubitemid 30155814)
18. Kaefer, M., S.J. Piva, J.A. de Carvalho, D.B. da Silva, A.M. Becker, A.C. Coelho, M.M. Duarte, and R.N. Moresco. 2010. Association between ischemia modified albumin, inflammation and hyperglycemia in type 2 diabetes mellitus. Clinical Biochemistry 43: 450-454.
19. Tatsch, E., G.V. Bochi, R.S. Pereira, H. Kober, V.A. Agertt, M.M.A. Campos, P. Gomes, M.M. Duarte, and R.N. Moresco. 2011. A simple and inexpensive automated technique for measurement of serum nitrite/nitrate. Clinical Biochemistry 44: 348-350.
20. Friedewald, W.T., R.I. Levy, and D.S. Fredrickson. 1972. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry 18: 499-502.
21. Levey, A.S., J.P. Bosch, J.B. Lewis, T. Greene, N. Rogers, and D. Roth. 1999. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Annals of Internal Medicine 130: 461-470. (Pubitemid 29135798)
22. Park, H.S., J.Y. Park, and R. Yu. 2005. Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-α and IL-6. Diabetes Research and Clinical Practice 29: 29-35. (Pubitemid 40813409)
23. Malnick, S.D.H., and H. Knobler. 2006. The medical complications of obesity. QJM: Monthly Journal of the Association of Physicians 99: 565-579. (Pubitemid 44540533)
24. Kopp, H.P., C.W. Kopp, A. Festa, K. Krzyzanowska, S. Kriwanek, E. Roka, and G. Schernthaner. 2003. Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients. Arteriosclerosis, Thrombosis, and Vascular Biology 23: 1042-1047. (Pubitemid 36713558)
25. Vincent, H.K., and A.G. Taylor. 2006. Biomarkers and potential mechanisms of obesity-induced oxidant stress in humans. International Journal of Obesity 30: 400-418.
26. Elmarakby, A.A., and J.C. Sullivan. 2012. Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy. Cardiovascular Therapeutics 30: 49-59.
27. Ouchi, N., J.L. Parker, J.J. Lugus, and K. Walsh. 2011. Adipokines in inflammation and metabolic disease. Nature Reviews Immunology 11: 85-97.
28. Pickup, J.C., M.B. Mattock, G.D. Chusney, and D. Burt. 1997. NIDDM as a disease of the innate immune system: Association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 40: 1286-1292. (Pubitemid 27469668)
29. Poirier, P., T.D. Giles, G.A. Bray, Y. Hong, J.S. Stern, F.X. Pi-Sunyer, and R.H. Eckel. 2006. Obesity and cardiovascular disease: Pathophysiology, evaluation, and effect of weight loss: An update of the 1997 American Heart Association scientific statement on obesity and heart disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 113: 898-918.
30. Tseng, C.H. 2009. Differential dyslipidemia associated with albuminuria in type 2 diabetic patients in Taiwan. Clinical Biochemistry 42: 1019-1024.
31. Thoenes, M., R.J. Reil, B.V. Khan, P. Bramlage, M. Volpe, W. Kirch, and M. Böhm. 2009. Abdominal obesity is associated with microalbuminuria and an elevated cardiovascular risk profile in patients with hypertension. Vascular Health and Risk Management 5: 577-585.
32. Elahi, M.M., K.M. Naseem, and B.M. Matata. 2007. Nitric oxide in blood. The nitrosative-oxidative disequilibrium hypothesis on the pathogenesis of cardiovascular disease. Federation of European Biochemical Societies Journal 274: 906-923. (Pubitemid 46204411)
33. Duarte, M.M.M.F., J.B.T. Rocha, R.N. Moresco, T. Duarte, I.B. da Cruz, V.L. Loro, and M.R. Schetinger. 2009. Association between ischemia modified albumin, lipids and inflammation biomarkers in patients with hypercholesterolemia. Clinical Biochemistry 42: 666-671.
34. Gottlieb, M.G.V., I.B. da Cruz, M.M. Duarte, R.N. Moresco, M. Wiehe, C.H. Schwanke, and L.C. Bodanese. 2010. Associations among metabolic syndrome, ischemia, inflammatory, oxidative, and lipids biomarkers. Journal of Clinical Endocrinology and Metabolism 95: 586-591.
35. Bhagavan, N.V., J.S. Ha, J.H. Park, S.A. Honda, C.N. Rios, C. Sugiyama, G.K. Fujitani, I.K. Takeuchi, and C.E. Ha. 2009. Utility of serum fatty acid concentrations as a marker for acute myocardial infarction and their potential role in the formation of ischemia-modified albumin: A pilot study. Clinical Chemistry 55: 1588-1590.